Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Diagnostic value of combined ¹⁸F-FDG PET/MRI for staging and restaging in paediatric oncology.

Pfluger T, Melzer HI, Mueller WP, Coppenrath E, Bartenstein P, Albert MH, Schmid I.

Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1745-55. doi: 10.1007/s00259-012-2228-3. Epub 2012 Aug 28.

PMID:
22926713
2.
3.

Diagnostic accuracy of whole-body PET/MRI and whole-body PET/CT for TNM staging in oncology.

Heusch P, Nensa F, Schaarschmidt B, Sivanesapillai R, Beiderwellen K, Gomez B, Köhler J, Reis H, Ruhlmann V, Buchbender C.

Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):42-8. doi: 10.1007/s00259-014-2885-5. Epub 2014 Aug 12.

PMID:
25112399
4.

Diagnostic accuracy of integrated (18)F-FDG PET/CT for restaging patients with malignant germ cell tumours.

Sharma P, Jain TK, Parida GK, Karunanithi S, Patel C, Sharma A, Thulkar S, Julka PK, Bal C, Kumar R.

Br J Radiol. 2014 Aug;87(1040):20140263. doi: 10.1259/bjr.20140263. Epub 2014 Jun 4.

5.

The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis.

Mueller WP, Melzer HI, Schmid I, Coppenrath E, Bartenstein P, Pfluger T.

Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):356-63. doi: 10.1007/s00259-012-2278-6. Epub 2012 Oct 25.

PMID:
23096080
6.

Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI.

Schaarschmidt BM, Heusch P, Buchbender C, Ruhlmann M, Bergmann C, Ruhlmann V, Schlamann M, Antoch G, Forsting M, Wetter A.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):92-102. doi: 10.1007/s00259-015-3145-z. Epub 2015 Aug 6.

PMID:
26243264
7.

Utility of (18)F-FDG PET-CT in staging and restaging of patients with malignant salivary gland tumours: a single-institutional experience.

Sharma P, Jain TK, Singh H, Suman SK, Faizi NA, Kumar R, Bal C, Malhotra A, Kumar R.

Nucl Med Commun. 2013 Mar;34(3):211-9. doi: 10.1097/MNM.0b013e32835bc4c4.

PMID:
23353886
8.

Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.

Kleis M, Daldrup-Link H, Matthay K, Goldsby R, Lu Y, Schuster T, Schreck C, Chu PW, Hawkins RA, Franc BL.

Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):23-36. doi: 10.1007/s00259-008-0911-1. Epub 2008 Aug 22.

PMID:
18719909
9.

Defining optimal tracer activities in pediatric oncologic whole-body 18F-FDG-PET/MRI.

Gatidis S, Schmidt H, la Fougère C, Nikolaou K, Schwenzer NF, Schäfer JF.

Eur J Nucl Med Mol Imaging. 2016 Dec;43(13):2283-2289. Epub 2016 Aug 26.

PMID:
27565153
10.

Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?

Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M.

Acta Gastroenterol Belg. 2007 Oct-Dec;70(4):331-8.

PMID:
18330088
11.

Simultaneous whole-body ¹⁸F-FDG PET-MRI in primary staging of breast cancer: a pilot study.

Taneja S, Jena A, Goel R, Sarin R, Kaul S.

Eur J Radiol. 2014 Dec;83(12):2231-2239. doi: 10.1016/j.ejrad.2014.09.008. Epub 2014 Sep 28.

PMID:
25282709
12.

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.

Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, van Dalen EC.

Cochrane Database Syst Rev. 2015 Sep 29;(9):CD009263. doi: 10.1002/14651858.CD009263.pub2. Review.

13.

A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.

PMID:
19687736
14.

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.

Giraudo C, Raderer M, Karanikas G, Weber M, Kiesewetter B, Dolak W, Simonitsch-Klupp I, Mayerhoefer ME.

Invest Radiol. 2016 Mar;51(3):163-9. doi: 10.1097/RLI.0000000000000218.

15.

Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.

Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.

Scand J Urol Nephrol. 2011 Mar;45(2):122-8. doi: 10.3109/00365599.2010.544672. Epub 2011 Jan 13.

PMID:
21231796
16.

Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.

Klenk C, Gawande R, Uslu L, Khurana A, Qiu D, Quon A, Donig J, Rosenberg J, Luna-Fineman S, Moseley M, Daldrup-Link HE.

Lancet Oncol. 2014 Mar;15(3):275-85. doi: 10.1016/S1470-2045(14)70021-X. Epub 2014 Feb 19.

PMID:
24559803
17.

¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.

Groheux D, Hindié E, Marty M, Espié M, Rubello D, Vercellino L, Bousquet G, Ohnona J, Toubert ME, Merlet P, Misset JL.

Eur J Radiol. 2014 Oct;83(10):1925-33. doi: 10.1016/j.ejrad.2014.05.037. Epub 2014 Jun 17.

PMID:
24985086
18.

Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.

Lepoutre-Lussey C, Caramella C, Bidault F, Déandreis D, Berdelou A, Al Ghuzlan A, Hartl D, Borget I, Gimenez-Roqueplo AP, Dumont F, Deschamps F, Nascimento C, Lumbroso J, Guillaud Bataille M, Schlumberger M, Baudin E, Leboulleux S.

Eur J Nucl Med Mol Imaging. 2015 May;42(6):868-76. doi: 10.1007/s00259-015-3003-z. Epub 2015 Feb 13.

PMID:
25676472
19.

Imaging of malignant lymphomas with F-18 FDG coincidence detection positron emission tomography.

Hwang K, Park CH, Kim HC, Kim H, Yoon S, Pai M, Kim S.

Clin Nucl Med. 2000 Oct;25(10):789-95.

PMID:
11043718
20.

¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.

Melzer HI, Coppenrath E, Schmid I, Albert MH, von Schweinitz D, Tudball C, Bartenstein P, Pfluger T.

Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1648-58. doi: 10.1007/s00259-011-1843-8. Epub 2011 May 27.

PMID:
21617976

Supplemental Content

Support Center